Table 3.

Association of EAT thickness with adverse outcomes in the GDM group (n = 314)

	Cases with adverse outcomes	With adverse outcomes	Without adverse outcomes	P*	OR (95%CI)	P#
Total	91 (29%)	7.29 ± 0.66	6.27 ± 0.64	< 0.001	8.28 (5.10–13.43)	< 0.001
Large size for gestational age	54 (17%)	7.19 ± 0.80	6.43 ± 0.73	< 0.001	3.47 (2.29–5.26)	< 0.001
Neonatal hypoglycemia	23 (7%)	7.25 ± 0.73	6.51 ± 0.77	< 0.001	3.10 (1.78–5.37)	< 0.001
Admission to NICU	54 (17%)	7.28 ± 0.65	6.41 ± 0.74	< 0.001	4.38 (2.81–6.84)	< 0.001
Preterm delivery	41 (13%)	7.36 ± 0.53	6.44 ± 0.76	< 0.001	4.67 (2.84–7.68)	< 0.001
Hyperbilirubinemia	23 (7%)	7.39 ± 0.64	6.50 ± 0.77	< 0.001	4.04 (2.24–7.28)	< 0.001

CI Confidence interval, EAT Epicardial adipose tissue, GDM Gestational diabetes mellitus, NICU Neonatal intensive care unit, OR odds ratio

P^*: P-value of independent-samples t-test

P^#: P-value of univariate regression between epicardial adipose tissue thickness and adverse outcomes using generalized linear models